Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer

Oskar Vilhelmsson Timmermand, Erik Larsson, Sven-Erik Strand and Thuy Tran
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1485;
Oskar Vilhelmsson Timmermand
1Medical Radiation Physics, Clinical Sciences, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Larsson
1Medical Radiation Physics, Clinical Sciences, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven-Erik Strand
1Medical Radiation Physics, Clinical Sciences, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thuy Tran
2Lund University Bioimaging Center, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 1485

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Oskar Vilhelmsson Timmermand1,
  2. Erik Larsson1,
  3. Sven-Erik Strand1 and
  4. Thuy Tran2
  1. 1Medical Radiation Physics, Clinical Sciences, Lund, Sweden
  2. 2Lund University Bioimaging Center, Lund, Sweden

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to August 2023

AbstractFullPdf
Nov 2014500
Dec 2014200
Jan 2015500
Feb 2015300
Mar 2015300
Apr 2015300
Jul 2015400
Aug 2015400
Sep 20151200
Oct 2015100
Dec 2015100
Jan 2016100
Mar 2016200
Apr 2016400
Jun 2016400
Jul 2016400
Aug 2016100
Sep 2016500
Oct 2016700
Nov 2016900
Dec 2016600
Jan 20171600
Feb 2017500
Mar 2017400
Apr 2017800
May 2017600
Jun 2017700
Jul 20171400
Aug 2017700
Sep 2017500
Oct 2017400
Nov 2017700
Dec 2017100
Jan 2018100
Feb 2018400
Mar 20181200
Apr 2018500
May 2018500
Jun 2018300
Jul 2018600
Aug 2018500
Sep 2018300
Oct 2018400
Nov 2018800
Dec 2018200
Jan 2019700
Feb 20191000
Mar 2019200
Apr 2019300
May 2019400
Jun 2019300
Jul 20191000
Aug 2019300
Sep 2019700
Oct 20192600
Nov 2019400
Dec 2019500
Jan 20202100
Feb 2020200
Mar 2020600
Apr 2020600
May 20201000
Jun 2020200
Jul 2020900
Aug 20201400
Sep 20201800
Oct 2020300
Nov 2020800
Dec 20201200
Jan 2021600
Feb 2021800
Mar 20211400
Apr 2021700
May 20211000
Jun 2021400
Jul 2021500
Aug 2021700
Sep 2021700
Oct 2021800
Nov 2021700
Dec 2021300
Jan 2022800
Feb 2022400
Mar 2022500
Apr 2022400
May 20221200
Jun 2022700
Jul 2022300
Aug 2022300
Sep 2022200
Oct 2022100
Nov 2022400
Dec 2022300
Jan 2023100
Feb 2023400
Mar 2023300
Apr 2023200
May 2023700
Jun 2023700
Jul 2023300
Aug 2023800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
Oskar Vilhelmsson Timmermand, Erik Larsson, Sven-Erik Strand, Thuy Tran
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1485;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
Oskar Vilhelmsson Timmermand, Erik Larsson, Sven-Erik Strand, Thuy Tran
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1485;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Investigation of volume-of-interest (VOI) definition methods for estimating organ activity concentrations in quantitative SPECT (QSPECT)
  • 188Re-microspheres for selective intra-arterial radionuclide therapy (SIRT) in patients with HCC: Feasibility study
  • SUVmax of Normal Tissues in Pediatric and Adult Patients on FDG PET/MR
Show more Oncology: Basic, Translational & Therapy

MTA I: Radiopharmaceutical Therapy Posters

  • Enhanced stability of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy
  • Hematotoxicity after radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
  • Therapeutic Effect of I-131-labeled Chitosan Hydrogels on Treatment of Hepatic Cancer: Focused on In vivo Rodent Orthotopic Hepatic Cancer Models
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire